Dr. Hugh F Colvin Jr., MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 Park Offices Dr Ste 140, Research Triangle Park, NC 27709 Phone: 434-242-0031 |
News Archive
The Rare Disease Cures Accelerator-Data and Analytics Platform initiative officially launched its next phase on Tuesday establishing itself as the leading platform to accelerate rare disease treatment innovation.
The Methodist Hospital in Houston is one of three academic medical centers in the country to win a top patient satisfaction award from Press Ganey, a national consulting firm focused on improving health care performance.
THE cancer drug eribulin, originally developed from sea sponges, could give women with advanced triple negative breast cancer an average of five extra months of life, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today (Monday).
Neurologist Benjamin Brooks, who directs the MDA ALS Center at the University of Wisconsin-Madison, presented results of a trial of tamoxifen, a drug approved for the treatment of breast cancer, at a meeting of the American Academy of Neurology in April. The trial was supported in part by MDA.
New research from Queen Mary, University of London suggests that many cases of diabetes could be prevented by making use of existing prediction tools.
› Verified 4 days ago